Brain TACE (Tumor Necrosis Factor-α-Converting Enzyme) Contributes to Sympathetic Excitation in Heart Failure Rats

被引:28
|
作者
Yu, Yang [1 ]
Cao, Yiling [1 ]
Bell, Balyssa [1 ]
Chen, Xiaolei [1 ]
Weiss, Robert M. [1 ]
Felder, Robert B. [1 ,3 ]
Wei, Shun-Guang [1 ,2 ]
机构
[1] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA
[2] Univ Iowa, Carver Coll Med, Neurosci Grad Program, Iowa City, IA USA
[3] Vet Affairs Med Ctr, Iowa City, IA 52242 USA
基金
美国国家卫生研究院;
关键词
cytokines; hypothalamic paraventricular nucleus; inflammation; subfornical organ; RENIN-ANGIOTENSIN SYSTEM; TNF-ALPHA; SUBFORNICAL ORGAN; RECEPTOR; EXPRESSION; PRECURSOR; PROTEIN; ROLES; METALLOPROTEINASE; DISINTEGRIN;
D O I
10.1161/HYPERTENSIONAHA.119.12651
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
TNF-alpha (tumor necrosis factor-alpha) is initially synthesized as a transmembrane protein that is cleaved by TACE (TNF-alpha-converting enzyme) to release soluble TNF-alpha. The elevated level of TNF-alpha in the brain and circulation in heart failure (HF) suggests an increase in the TACE-mediated ectodomain shedding process. The present study sought to determine whether TACE is upregulated in cardiovascular/autonomic brain regions like subfornical organ and hypothalamic paraventricular nucleus in rats with ischemia-induced HF and whether TACE plays a role in TNF-alpha-driven sympathetic excitation. We found that TACE was expressed throughout the subfornical organ and paraventricular nucleus, with significantly higher levels in HF than in sham-operated (Sham) rats. Intracerebroventricular injection of recombinant TACE induced a mild increase in blood pressure, heart rate, and renal sympathetic nerve activity that peaked at 15 to 20 minutes in both Sham and HF rats. HF rats had a secondary prolonged increase in these variables that was prevented by the TNF-alpha inhibitor SPD304. Intracerebroventricular administration of the TACE inhibitor TNF-alpha protease inhibitor 1 decreased blood pressure, heart rate, and renal sympathetic nerve activity in Sham and HF rats, with an exaggerated reduction in heart rate and renal sympathetic nerve activity in the HF rats. Direct microinjection of TACE or TNF-alpha protease inhibitor 1 into paraventricular nucleus or subfornical organ of Sham and HF rats elicited blood pressure, heart rate, and renal sympathetic nerve activity responses similar to intracerebroventricular TACE or TNF-alpha protease inhibitor 1. Intracerebroventricular infusion of Ang II (angiotensin II) and IL (interleukin)-1 beta increased TACE expression in subfornical organ and paraventricular nucleus of normal rats. These data suggest that a TACE-mediated increase in soluble TNF-alpha in the brain contributes to sympathetic excitation in HF.
引用
收藏
页码:63 / 72
页数:10
相关论文
共 50 条
  • [1] Brain Tumor Necrosis Factor-α Converting Enzyme Contributes to Sympathetic Activation in Heart Failure Rats
    Wei, Shun-Guang
    Yu, Yang
    Weiss, Robert M.
    Felder, Robert B.
    FASEB JOURNAL, 2017, 31
  • [2] Heterocyclic inhibitors of tumor necrosis factor-α converting enzyme (TACE)
    Levin, Jeremy I.
    HETEROCYCLES, 2006, 70 : 691 - +
  • [3] Central Blockade Of Tumor Necrosis Factor-A-Converting Enzyme (tace) Ameliorates Neuroinflammation, Sympathetic Excitation And Cardiac Dysfunction In Heart Failure Rat
    Yu, Yang
    Xue, Baojian
    Li, Hanzeng
    Chen, Qing
    Li, Mingxuan
    Beltz, Terry
    Weiss, Robert M.
    Johnson, Alan K.
    Wei, Shunguang
    HYPERTENSION, 2021, 78
  • [4] Effects of Central Intervention of Tumor Necrosis Factor-α Converting Enzyme (TACE) on Neuroinflammation and Cardiac Function in Heart Failure
    Bell, Balyssa
    Yu, Yang
    Felder, Robert
    Wei, Shun-Guang
    FASEB JOURNAL, 2020, 34
  • [5] Tumor necrosis factor-α-converting enzyme (TACE) levels in periodontal diseases
    Bostanci, N.
    Emingil, G.
    Afacan, B.
    Han, B.
    Ilgenli, T.
    Atilla, G.
    Hughes, F. J.
    Belibasakis, G. N.
    JOURNAL OF DENTAL RESEARCH, 2008, 87 (03) : 273 - 277
  • [6] Domain organization of the human tumor necrosis factor-α converting enzyme (TACE)
    Miller, AB
    Moss, M
    Mitchell, J
    Clay, W
    Carter, HL
    Buckhart, W
    Chen, WJ
    Didsbury, J
    Hoffman, C
    Jin, C
    Kost, T
    Lambert, M
    Leesnitzer, MA
    McCauley, P
    Moyer, M
    Pahel, G
    Su, JL
    Becherer, JD
    Milla, M
    FASEB JOURNAL, 1997, 11 (09): : A1225 - A1225
  • [7] Is tumor necrosis factor-α-converting enzyme (TACE) a therapeutic target for neuroprotection?
    Wang, XK
    DRUGS OF THE FUTURE, 2005, 30 (07) : 755 - 757
  • [8] Design of selective and soluble inhibitors of tumor necrosis factor-α converting enzyme (TACE)
    Rabinowitz, MH
    Andrews, RC
    Becherer, JD
    Bickett, DM
    Bubacz, DG
    Conway, JG
    Cowan, DJ
    Gaul, M
    Glennon, K
    Lambert, MH
    Leesnitzer, MA
    McDougald, DL
    Moss, ML
    Musso, DL
    Rizzolio, MC
    JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (24) : 4252 - 4267
  • [9] Tumor necrosis factor-α converting enzyme
    Black, RA
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2002, 34 (01): : 1 - 5
  • [10] Genetic mapping of mouse tumor necrosis factor-α converting enzyme (Tace) to chromosome 12
    Yamazaki, K
    Mizui, Y
    Sagane, K
    Tanaka, I
    GENOMICS, 1998, 49 (02) : 336 - 337